Scholars Central

Conference abstractPublished 28 Jul 2016

Molecular Tumor Markers: Diagnosis and Therapy

Authors: Hussein A. Kaoud

Cairo University, Giza-Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Molecular tumor markers can be produced directly by tumor or non tumor cells as a response to the presence of a tumor. Most tumor markers are tumor antigens but not all tumor antigens can be used as tumor markers. Molecular markers are diagnostic, prognostic or predictive. The article discussed the molecular tumor markers; significance of each markers and its role in diagnosis, prognosis and prediction of tumor and tests used. It is used to distinguish tumor from normal tissue or to detect the presence of a tumor on the basis of measurements in the blood or secretions. And it is currently being put new molecular markers with an increased understanding of the molecular environment of the cell tumor and other disease cells. It can produce tumor markers directly from the tumor or by non-cancer cells in response to the presence of a tumor. Most tumor markers are tumor antigens but not all tumor antigens can be used as tumor markers. Concerning drug evaluation and check effects of drug treatment on the tumor, biomarkers perhaps can determine the appropriate dose in the early stages of a new antidepressant medication for cancer clinical development. Biomarkers and prognostic expects the natural course of cancer and excellence as a result of the tumor. They also help determine who to treat, how aggressively to treat and which candidates are likely to respond to a particular drug and the dose is most effective. Theranostic, use a combination of diagnosis and therapy sessions and can be different perception. Imaging can be used to track drug delivery within the body. However, imaging can also be used to stimulate drug releasing from the outside by external influences. These external influences to be laser light, temperature or ultrasound, for example. In the forefront, smart probes represent new innovative concepts for clinical application. Nanoparticles can be used to make selective surfaces for molecular interactions target. For example the population H biomarker present in the blood will be characterized fully, pads harvesting nano-particle has a great potential to improve the detection of the disease at an early stage and more treatable.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectGenetics & Molecular Biology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Hussein A. Kaoud”